Literature DB >> 11567749

Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: freshly prepared and aged model vaccines.

Y Shi1, H HogenEsch, S L Hem.   

Abstract

The ability of interstitial fluid to change the degree of adsorption of ovalbumin to aluminum hydroxide adjuvant or lysozyme to aluminum phosphate adjuvant was studied. Ovalbumin and lysozyme were almost completely eluted after exposure at 37 degrees C to sheep lymph fluid for 4h or 15 min, respectively. The ability of sheep lymph fluid to elute lysozyme from aluminum phosphate adjuvant did not change as the model vaccine aged. However, only 60% of the ovalbumin adsorbed to aluminum hydroxide adjuvant was eluted during exposure to sheep lymph fluid for 24h after the model vaccine aged for 11 weeks at 4 degrees C.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11567749     DOI: 10.1016/s0264-410x(01)00313-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

1.  Comparable quality attributes of hepatitis E vaccine antigen with and without adjuvant adsorption-dissolution treatment.

Authors:  Yue Zhang; Min Li; Fan Yang; Yufang Li; Zizheng Zheng; Xiao Zhang; Qingshan Lin; Ying Wang; Shaowei Li; Ningshao Xia; Jun Zhang; Qinjian Zhao
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  The role of adjuvant in mediating antigen structure and stability.

Authors:  Latoya Jones Braun; Aimee M Eldridge; Jessica Cummiskey; Kelly K Arthur; Deborah S Wuttke
Journal:  J Pharm Sci       Date:  2011-12-28       Impact factor: 3.534

3.  Concentration determination of a recombinant vaccine antigen adsorbed onto an alum adjuvant by chemiluminescent nitrogen detection.

Authors:  John V Amari; Philip Levesque; Zhirui Lian; Trish Lowden; Uditha deAlwis
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

Review 4.  Advances in aluminum hydroxide-based adjuvant research and its mechanism.

Authors:  Peng He; Yening Zou; Zhongyu Hu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance.

Authors:  Kimberly M Cirelli; Diane G Carnathan; Bartek Nogal; Jacob T Martin; Oscar L Rodriguez; Amit A Upadhyay; Chiamaka A Enemuo; Etse H Gebru; Yury Choe; Federico Viviano; Catherine Nakao; Matthias G Pauthner; Samantha Reiss; Christopher A Cottrell; Melissa L Smith; Raiza Bastidas; William Gibson; Amber N Wolabaugh; Mariane B Melo; Benjamin Cossette; Venkatesh Kumar; Nirav B Patel; Talar Tokatlian; Sergey Menis; Daniel W Kulp; Dennis R Burton; Ben Murrell; William R Schief; Steven E Bosinger; Andrew B Ward; Corey T Watson; Guido Silvestri; Darrell J Irvine; Shane Crotty
Journal:  Cell       Date:  2019-05-09       Impact factor: 41.582

Review 6.  Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases.

Authors:  Charles B Smarr; Paul J Bryce; Stephen D Miller
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

7.  Stability of a trivalent recombinant protein vaccine formulation against botulinum neurotoxin during storage in aqueous solution.

Authors:  Christina Vessely; Tia Estey; Theodore W Randolph; Ian Henderson; Julianne Cooper; Rajiv Nayar; Latoya Jones Braun; John F Carpenter
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

8.  Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer.

Authors:  Daming Zhu; Shuhui Huang; Holly McClellan; Weili Dai; Najam R Syed; Elizabeth Gebregeorgis; Kelly M Rausch; Gregory E D Mullen; Carole Long; Laura B Martin; David Narum; Patrick Duffy; Louis H Miller; Allan Saul
Journal:  Vaccine       Date:  2011-11-19       Impact factor: 3.641

9.  Patterns of binding of aluminum-containing adjuvants to Haemophilus influenzae type b and meningococcal group C conjugate vaccines and components.

Authors:  Robert B D Otto; Karena Burkin; Saba Erum Amir; Dennis T Crane; Barbara Bolgiano
Journal:  Biologicals       Date:  2015-07-17       Impact factor: 1.856

10.  Mechanism of immunopotentiation and safety of aluminum adjuvants.

Authors:  Harm Hogenesch
Journal:  Front Immunol       Date:  2013-01-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.